MASTERING THE SUPPLY CHAIN

CARBOGEN AMCIS

Abstract
After intense research investigations Heidelberg Pharma found a unique access to a fully synthetic route for alpha-Amanitin. With CARBOGEN AMCIS, Heidelberg Pharma developed a scalable and
economical route providing alpha-Amanitin now available for the development of new therapeutic ADC's.

Category
CMC: Small Molecules, Drug Substance

Keywords
CDMO, ADC, Antibody Drug Conjugates, Conjugation, HiPo, HPLC, CARBOGEN AMCIS, CRAMS,PR&D, Chromatography, cyclic peptide, cGMP manufacture, Aseptic fill and finish, Heidelberg Pharma

- Ms Vera Ivkovic, CARBOGEN AMCIS

x2